In addition, since we didn’t observe a difference in maternal serum ISG15 levels, downregulation of ISG15 levels in the maternal-fetal interface in preeclampsia can be linked to a local dysregulation rather than a systemic impact. The gene discussed is ISG15; the disease is preeclampsia.